XTX Topco Ltd

Position in GILD — Gilead Sciences, Inc.

CIK 1828301 LONDON, X0

Position in GILD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,411,258

+$7,385,329 QoQ

Shares Held

60,352

+559.2% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

XTX Topco Ltd holds $56,692,973 across 12 Drug Manufacturers - General names. GILD ranks #3 (14.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	60,566	$9,251,456
2	JNJ	Johnson & Johnson	36,844	$9,006,147
3	GILD	Gilead Sciences, Inc. This page	60,352	$8,411,258
4	PFE	Pfizer Inc	275,144	$7,726,043
5	AMGN	Amgen Inc	19,756	$6,951,148
6	ABBV	AbbVie Inc.	26,692	$5,805,243
7	MRK	Merck & Co., Inc.	34,803	$4,186,452
8	LLY	ELI LILLY & Co	4,218	$3,879,589

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,411,258	60,352	+559.2%	Shares	Defined	2026-05-15
2025-03-31	$1,025,929	9,156	+76.8%	Shares	Defined	2025-05-08
2024-12-31	$478,476	5,180	-25.2%	Shares	Defined	2025-02-13
2024-09-30	$580,508	6,924	-39.4%	Shares	Defined	2024-11-14
2024-03-31	$836,954	11,426	+41.6%	Shares	Defined	2024-05-13
2023-09-30	$604,765	8,070	-21.3%	Shares	Defined	2023-11-13
2023-06-30	$790,352	10,255	+109.2%	Shares	Defined	2023-08-14
2022-12-31	$420,836	4,902	+3.1%	Shares	Defined	2023-02-14
2022-09-30	$293,274	4,754	-75.5%	Shares	Defined	2022-11-14
2022-06-30	$1,197,197	19,369	+71.7%	Shares	Defined	2022-08-15
2022-03-31	$670,596	11,280	+108.2%	Shares	Defined	2022-05-13
2021-12-31	$393,328	5,417	-62.7%	Shares	Defined	2022-02-11
2021-09-30	$1,015,688	14,541	—	Shares	Defined	2021-11-12
No filing history on record for this holder in this stock.